Pasireotide Extended-Release Injection and Zohydro ER Capsules
Determining the interaction of Pasireotide Extended-Release Injection and Zohydro ER Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Zoladex
- Pasireotide Extended-Release Injection-Zoladex (Goserelin Implant 10.8 mg)
- Pasireotide Extended-Release Injection-Zoladex (Goserelin Implant 3.6 mg)
- Pasireotide Extended-Release Injection-Zoladex 3-Month
- Pasireotide Extended-Release Injection-Zoladex Implant
- Pasireotide Extended-Release Injection-Zolate
- Zohydro ER Capsules-Pasireotide Injection
- Zohydro ER Capsules-Pasireotide Subcutaneous
- Zohydro ER Capsules-Patanase
- Zohydro ER Capsules-Patiromer
- Zohydro ER Capsules-Patiromer Sorbitex Calcium
- Zohydro ER Capsules-Pavacot